We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

88 hedge funds and large institutions have $187M invested in Vanda Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 88 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $15.4M | Put options by funds: $3.89M

81.3% more ownership

Funds ownership: 0% → 81.3% (+81%)

Holders
88
Holders Change
+88
Holders Change %
–
% of All Funds
2.86%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
88
Increased
–
Reduced
–
Closed
–
Calls
$15.4M
Puts
$3.89M
Net Calls
+$11.5M
Net Calls Change
+$11.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

VNDA Hedge Fund Activity: Q2 2013 in Review

88 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q2 2013, worth a combined $187M.

Buyers outnumbered sellers: 88 funds opened new VNDA positions and 0 closed out — a net gain of 88 holders — while 0 added to existing stakes and 0 trimmed.

  • 88 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $187M of Vanda Pharmaceuticals stock for Q2 2013.
  • 88 funds opened new Vanda Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +88 holders.

Based on aggregated 13F filings for Q2 2013.